1. Home
  2. QXO vs TWST Comparison

QXO vs TWST Comparison

Compare QXO & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QXO Inc.

QXO

QXO Inc.

N/A

Current Price

$11.50

Market Cap

11.3B

Sector

Technology

ML Signal

N/A

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

N/A

Current Price

$120.36

Market Cap

9.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QXO
TWST
Founded
1988
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
9.2B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
QXO
TWST
Price
$11.50
$120.36
Analyst Decision
Strong Buy
Buy
Analyst Count
19
13
Target Price
$24.06
★ $168.25
AVG Volume (30 Days)
★ 20.6M
2.4M
Earning Date
11-17-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 63.89
EPS
★ N/A
N/A
Revenue
$54,516,941.00
★ $376,572,000.00
Revenue This Year
$104.99
$21.17
Revenue Next Year
$32.26
$20.24
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 21.19
20.32
52 Week Low
$10.04
$23.30
52 Week High
$27.61
$219.71

Technical Indicators

Market Signals
Indicator
QXO
TWST
Relative Strength Index (RSI) 50.33 38.85
Support Level $11.14 $79.90
Resistance Level $12.71 $155.44
Average True Range (ATR) 0.65 15.43
MACD 0.19 -3.39
Stochastic Oscillator 50.54 4.11

Price Performance

Historical Comparison
QXO
TWST

About QXO QXO Inc.

QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: